Groups suggest tweaks to FDA’s guidance on developing drugs to treat radiation exposure
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyResearch, Design and Development